Meeting on the Med 2021 | Improving education in cell therapy

Emanuele Ostuni, Head of Europe, Cell and Gene Therapy, Novartis Oncology, East Hanover, NJ, discusses the importance of educating patients on novel therapeutic modalities being developed for hematological malignancies such as lymphoma, myeloma and leukemia in order to give patients a better understanding of their treatment options. He also points out that improved education for healthcare professionals on novel treatment options such as CAR-T therapy is needed in order for them to be able to make more informed decisions for their patients. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.